uric acid has been researched along with Bouillaud Disease in 10 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uric acid to lymphocyte ratio, combining the effect of uric acid and lymphocyte count, produced more prognostic value in elderly patients with rheumatic heart disease undergoing valve replacement surgery, which could be considered as a preoperative risk-stratified method." | 7.91 | Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. ( Chen, WJ; Duan, CY; Geng, QS; Jiang, L; Qin, TH; Wei, XB; Yu, Y, 2019) |
| "We evaluated the relationship between admission serum uric acid (SUA) and in-hospital and one-year mortality after valve replacement surgery (VRS) for patients with rheumatic heart disease (RHD)." | 7.85 | Serum uric acid as a simple risk factor in patients with rheumatic heart disease undergoing valve replacement surgery. ( Chen, J; Feng, D; He, PC; Jiang, L; Liu, YH; Tan, N; Wei, XB; Yu, DQ, 2017) |
| "Uric acid to lymphocyte ratio, combining the effect of uric acid and lymphocyte count, produced more prognostic value in elderly patients with rheumatic heart disease undergoing valve replacement surgery, which could be considered as a preoperative risk-stratified method." | 3.91 | Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. ( Chen, WJ; Duan, CY; Geng, QS; Jiang, L; Qin, TH; Wei, XB; Yu, Y, 2019) |
| "We evaluated the relationship between admission serum uric acid (SUA) and in-hospital and one-year mortality after valve replacement surgery (VRS) for patients with rheumatic heart disease (RHD)." | 3.85 | Serum uric acid as a simple risk factor in patients with rheumatic heart disease undergoing valve replacement surgery. ( Chen, J; Feng, D; He, PC; Jiang, L; Liu, YH; Tan, N; Wei, XB; Yu, DQ, 2017) |
| "Osteonecrosis was detected in 10/365 patients (2." | 1.29 | [Rheumatologic manifestations in heart transplant recipients. A cross-sectional study of 365 patients]. ( Bourgeois, P; Cabrol, A; Frih, L; Gandjbackch, I; Koeger, AC; Lang, T; Rozenberg, S, 1993) |
| "In patients with severe heart decompensation, there was an appreciable activation of xanthine oxidase, which correlated, as a rule, with high hyperuricemia." | 1.28 | [Changes in xanthine oxidase activity in patients with circulatory failure]. ( Bakhtiiarov, ZA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, XB | 2 |
| Jiang, L | 2 |
| Liu, YH | 1 |
| Feng, D | 1 |
| He, PC | 1 |
| Chen, J | 1 |
| Yu, DQ | 1 |
| Tan, N | 1 |
| Chen, WJ | 1 |
| Duan, CY | 1 |
| Qin, TH | 1 |
| Yu, Y | 1 |
| Geng, QS | 1 |
| Timek, TA | 1 |
| KELLGREN, JH | 1 |
| Steele, P | 1 |
| Rainwater, J | 1 |
| Rozenberg, S | 1 |
| Frih, L | 1 |
| Lang, T | 1 |
| Koeger, AC | 1 |
| Cabrol, A | 1 |
| Gandjbackch, I | 1 |
| Bourgeois, P | 1 |
| Ivanchenko, KN | 1 |
| Belov, VA | 1 |
| Bakhtiiarov, ZA | 2 |
| Mit'kin, AF | 1 |
10 other studies available for uric acid and Bouillaud Disease
| Article | Year |
|---|---|
Serum uric acid as a simple risk factor in patients with rheumatic heart disease undergoing valve replacement surgery.
Topics: Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Rheumatic Heart Disease; Risk Factors; Ur | 2017 |
Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery.
Topics: Biomarkers; Female; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Hyperuricemia; | 2019 |
Commentary: The golden ratio.
Topics: Aged; Humans; Lymphocyte Count; Rheumatic Heart Disease; Uric Acid | 2019 |
THE EPIDEMIOLOGY OF RHEUMATIC DISEASES.
Topics: Arthritis; Arthritis, Rheumatoid; Blood; Colitis; Colitis, Ulcerative; Crohn Disease; Enteritis; Epi | 1964 |
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
Topics: Atrial Fibrillation; Blood Coagulation; Blood Platelets; Cell Survival; Heart Valve Prosthesis; Huma | 1980 |
[Rheumatologic manifestations in heart transplant recipients. A cross-sectional study of 365 patients].
Topics: Adolescent; Adult; Aged; Arthritis, Gouty; Arthritis, Rheumatoid; Child; Female; Heart Transplantati | 1993 |
[Disorders of nitrogen metabolism in circulatory insufficiency].
Topics: Adult; Aged; Ammonia; Blood Circulation; Blood Proteins; Coronary Disease; Creatinine; Humans; Middl | 1977 |
[Uric acid of plasma in patients with rheumatic heart disease, rheumatoid arthritis and systemic lupus erythematosus and its dynamics during treatment].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cardiac Glycosides; | 1976 |
[Changes in xanthine oxidase activity in patients with circulatory failure].
Topics: Female; Heart Failure; Humans; Male; Rheumatic Heart Disease; Uric Acid; Xanthine Oxidase | 1989 |
[Effect of acetylsalicylic acid on uric acid metabolism in patients with rheumatism].
Topics: Adult; Aspirin; Circadian Rhythm; Female; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Mit | 1988 |